Citigroup
AERI

Citigroup’s Aerie Pharmaceuticals AERI Stock Holding History

Citigroup’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-5,000
Closed -$189K – 7376
2016
Q3 		$189K Buy
+5,000
New +$110K ﹤0.01% 4703

Citigroup's AERI Position: Q4 2022 in Review

Citigroup sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 1,100,775 shares — an estimated $16.7M sold.

Citigroup first reported a position in AERI in Q4 2013 and held it in 36 quarters. The position peaked at $22.3M in Q4 2019. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.

  • Citigroup reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Citigroup sold 1,100,775 Aerie Pharmaceuticals shares in Q4 2022, an estimated $16.7M.
  • Citigroup first reported a position in Aerie Pharmaceuticals in Q4 2013 and held it in 36 quarters.
  • Citigroup's Aerie Pharmaceuticals position peaked at $22.3M in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.

Based on Citigroup's 13F filing for Q4 2022, filed 9 Feb 2023.